The impaired DCs fail to properly activate CD8+ and CD4+ T-cells, which results in decreased T-cell infiltration, reduced cytolytic activity, and compromised neoantigen recognition, ultimately potentiating tumor immune evasion [60,61]. The gene discussed is CD4; the disease is neoplasm.